Tom van den Bogert

Falco Biotherapeutics BV operates as a biopharmaceutical company. It focuses on the development of (ElCams) engineered loop containing affinity molecules, a category of therapeutic, diagnostic, and prophylactic protein-based health care products to treat inflammation and infectious diseases. The company was founded in 2006 and is located in Amsterdam, The Netherlands

Caelus Pharmaceuticals BV operates as a biotechnology company that develops microbiome therapeutics for the reduction of insulin resistance and prevention of type 2 diabetes in people with metabolic syndrome. The firm is dedicated to the commercialisation of functional food and pharmabiotic products for the prevention and early treatment of cardio metabolic diseases-based on the correlation between the intestinal microbiome and health. The company was founded by Willem de Vos and Max Nieuwdorp and is headquartered in Amsterdam, the Netherlands.